Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX
- 15 September 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (6), 2123-2131
- https://doi.org/10.1182/blood-2002-02-0513
Abstract
Chronic lymphocytic leukemia (CLL) is associated with a variety of immunologic disturbances. Hypogammaglobulinemia and autoimmune phenomena are both often present in this disease. In contrast, humoral or cellular antitumor responses are rarely observed. It has been previously shown that antigens detected in patients with malignant diseases can provide information regarding intracellular molecules engaged in the transformation process and can identify tumor antigens that may be useful for development of immunotherapeutic strategies. Serologic identification by recombinant expression cloning (SEREX) has been demonstrated to be a useful method to detect tumor and tumor-associated antigens in a variety of malignancies. Although this approach is complicated in CLL, we used a modified SEREX approach and identified 14 antigens (KW-1 to KW-14) using this methodology. Several clones showed a restricted expression pattern in normal tissues. Moreover, distinctive expression of splice variants and aberrant gene expression in malignant tissue were detected. In this study, 6 antigens were detected exclusively in patients with CLL. Eight antigens were detected also in lymphoma patients. Healthy donors showed antibody responses against only 3 of the identified antigens. T cells with specific cytotoxicity against peptides derived from the 2 antigens tested could be generated from healthy donors. These findings demonstrate that humoral and cellular immune responses against CLL-associated antigens can be detected. Ongoing experiments investigate their potential for the development of immunotherapeutic strategies.Keywords
This publication has 57 references indexed in Scilit:
- Induction of cytotoxic T-cell responses against immunoglobulin V region–derived peptides modified at human leukocyte antigen–A2 binding residuesBlood, 2001
- Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patientsJCI Insight, 2001
- Simultaneous expression of different immunogenic antigens in acute myeloid leukemiaExperimental Hematology, 2000
- Lens Epithelium-Derived Growth Factor: Effects on Growth and Survival of Lens Epithelial Cells, Keratinocytes, and FibroblastsBiochemical and Biophysical Research Communications, 2000
- Assignment1 of the L11 ribosomal protein gene (RPL11) to human chromosome 1p36.1→p35 by in situ hybridizationCytogenetic and Genome Research, 1999
- CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.JCI Insight, 1997
- Isolation and Fine Mapping of 16 Novel Human Zinc Finger-Encoding cDNAs Identify Putative Candidate Genes for Developmental and Malignant DisordersGenomics, 1995
- Human Somatostatin Receptor Genes: Localization of SSTR5 to Human Chromosome 20p11.2Genomics, 1993
- Ikaros, an Early Lymphoid-Specific Transcription Factor and a Putative Mediator for T Cell CommitmentScience, 1992